Homepage - Pieris AG

The anticalin company

Pieris Achieves Second Milestone Payment in Daiichi Sankyo Collaboration to Develop Anticalin^® Therapeutics

Home|Disclaimer/Impressum|Sitemap|Contact|Careers|^© Pieris AG 2013